Engineers Gate Manager LP

Position in NVS — Novartis AG

CIK 1620220 NEW YORK, NY

Position in NVS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,529,051

+$4,325,693 QoQ

Shares Held

28,899

+1859.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#279

of 1,603 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Engineers Gate Manager LP holds $31,594,540 across 11 Drug Manufacturers - General names. NVS ranks #3 (14.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	112,886	$14,262,017
2	LLY	ELI LILLY & Co	6,562	$7,870,660
3	NVS	Novartis AG This page	28,899	$4,529,051
4	ABBV	AbbVie Inc.	4,125	$1,038,015
5	JNJ	Johnson & Johnson	3,449	$875,942
6	OGN	Organon & Co.	52,692	$713,449
7	AZN	Astrazeneca PLC	3,235	$613,420
8	NVO	Novo Nordisk A S	9,751	$467,462

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,529,051	28,899	+1859.3%	Shares	Sole	2026-08-14
2025-12-31	$203,358	1,475	-85.8%	Shares	Sole	2026-02-17
2025-09-30	$1,327,796	10,354	-6.8%	Shares	Sole	2025-11-14
2025-06-30	$1,344,421	11,110	+13.8%	Shares	Sole	2025-08-14
2025-03-31	$1,087,933	9,759	-67.4%	Shares	Sole	2025-05-15
2024-12-31	$2,910,542	29,910	+404.6%	Shares	Sole	2025-02-14
2024-09-30	$681,723	5,927	-53.1%	Shares	Sole	2024-11-14
2024-06-30	$1,346,506	12,648	-67.3%	Shares	Sole	2024-08-14
2024-03-31	$3,741,516	38,680	+198.0%	Shares	Sole	2024-05-15
2023-12-31	$1,310,388	12,978	+212.1%	Shares	Sole	2024-02-14
2023-09-30	$423,533	4,158	-64.3%	Shares	Sole	2023-11-14
2023-06-30	$1,176,206	11,656	+118.8%	Shares	Sole	2023-08-14
2022-09-30	$404,981	5,328	-44.5%	Shares	Sole	2022-11-14
2022-06-30	$811,488	9,600	+249.1%	Shares	Sole	2022-08-15
2020-03-31	$226,737	2,750	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.